These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 993400)

  • 1. Tubular apocrine adenoma.
    Umbert P; Winkelmann RK
    J Cutan Pathol; 1976; 3(2):75-87. PubMed ID: 993400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
    Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
    An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.
    Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
    Am J Dermatopathol; 2008 Feb; 30(1):51-3. PubMed ID: 18212545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubulopapillary Cystic Adenoma With Apocrine Differentiation: A Unifying Concept for Syringocystadenoma Papilliferum, Apocrine Gland Cyst, and Tubular Papillary Adenoma.
    Ansai SI; Anan T; Fukumoto T; Saeki H
    Am J Dermatopathol; 2017 Nov; 39(11):829-837. PubMed ID: 28033156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is tubular apocrine adenoma a distinct clinical entity?
    Ishiko A; Shimizu H; Inamoto N; Nakmura K
    Am J Dermatopathol; 1993 Oct; 15(5):482-7. PubMed ID: 8238787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
    Aktepe F; Demir Y; Dilek FH
    Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex sweat gland hamartoma: A case report.
    Skopec Z; Berrebi KG; Stone M; Liu V
    J Cutan Pathol; 2023 Mar; 50(3):243-246. PubMed ID: 36323653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tubulo-papillary apocrine adenoma in association with syringocystadenoma papilliferum].
    Ayadi L; Mallouli M; Kallel R; Charfi S; Makni S; Boudawara TS; Gouiaa N
    Ann Pathol; 2016 Oct; 36(5):355-357. PubMed ID: 27693311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure apocrine nevus: a report of 4 cases.
    Cordero SC; Royer MC; Rush WL; Hallman JR; Lupton GP
    Am J Dermatopathol; 2012 May; 34(3):305-9. PubMed ID: 22317889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of tubular apocrine adenoma with syringocystadenoma papilliferum.
    Ansai S; Watanabe S; Aso K
    J Cutan Pathol; 1989 Aug; 16(4):230-6. PubMed ID: 2551940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubular apocrine adenoma.
    Toribio J; Zulaica A; Peteiro C
    J Cutan Pathol; 1987 Apr; 14(2):114-7. PubMed ID: 3036918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
    Wong TY; Suster S; Cheek RF; Mihm MC
    Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal carcinoma arising from a syringocystadenoma papilliferum in a nevus sebaceus of Jadassohn.
    Hügel H; Requena L
    Am J Dermatopathol; 2003 Dec; 25(6):490-3. PubMed ID: 14631190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of tubular apocrine adenoma with syringocystadenoma papilliferum arising in nevus sebaceus.
    Ahn BK; Park YK; Kim YC
    J Dermatol; 2004 Jun; 31(6):508-10. PubMed ID: 15235197
    [No Abstract]   [Full Text] [Related]  

  • 15. A Case of Syringocystadenoma Papilliferum with Tubular Papillary Adenoma of the Chest.
    Ito K; Ansai SI; Saeki H
    J Nippon Med Sch; 2017; 84(2):79-82. PubMed ID: 28502963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spiradenoma associated with apocrine adenoma component.
    Michal M
    Pathol Res Pract; 1996 Nov; 192(11):1135-9; discussion 1140-1. PubMed ID: 9122033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trilogy Revisited: A Case Report of Co-Existing Nevus Sebaceous with Syringocystadenoma Papilliferum and Tubular Apocrine Adenoma.
    Bardia A; Chatterjee D; Vinay K
    Indian Dermatol Online J; 2021; 12(4):577-579. PubMed ID: 34430463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin.
    Liau JY; Tsai JH; Huang WC; Lan J; Hong JB; Yuan CT
    Hum Pathol; 2018 Mar; 73():59-65. PubMed ID: 29241739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringocystadenoma papilliferum: light and electron microscopic studies.
    Niizuma K
    Acta Derm Venereol; 1976; 56(5):327-36. PubMed ID: 78616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringocystadenoma papilliferum on the male nipple.
    Shindo M; Yamada N; Yoshida Y; Yamamoto O; Morino S
    J Dermatol; 2011 Jun; 38(6):593-6. PubMed ID: 21914158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.